68GA-DOTA-dPNE

DRUG2 trials

Sponsors

Peking Union Medical College Hospital

Conditions

Breast CancerTumor Immunity

Early Phase 1

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

RecruitingNCT06411678

Peking Union Medical College HospitalBreast Cancer

Start: 2024-05-10End: 2025-12-01Target: 50Updated: 2025-06-17

Unknown Phase

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor

RecruitingNCT06844110

Peking Union Medical College HospitalTumor Immunity

Start: 2025-03-01End: 2026-03-30Target: 50Updated: 2025-08-05